Why Herbalife is on investors’ radar now

Herbalife (HLF) has caught attention after a period of sharp share price moves, with the stock up about 34% over the past month and more than doubling in the past 3 months.

Beyond the recent surge, Herbalife’s 1 year total shareholder return of about 216% contrasts with a 5 year total shareholder return of around a 68% decline. This suggests strong recent momentum after a difficult longer stretch.

If Herbalife’s sharp rebound has you reassessing where momentum might appear next, it could be worth scanning fast growing stocks with high insider ownership as a starting point for other ideas.

With Herbalife trading at $17.24, above its US$14.00 analyst price target but with an indicated 31% intrinsic discount, investors face a classic puzzle: is the recent rally overdone, or is the market still underestimating future growth?

Most Popular Narrative: 23.1% Overvalued

Compared to Herbalife's last close at $17.24, the most followed narrative points to a fair value of $14.00, putting recent price strength under scrutiny.

The analysts have a consensus price target of $9.333 for Herbalife based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $11.0, and the most bearish reporting a price target of just $7.0.

The narrative leans on modest revenue growth, thinner profit margins, and a higher future earnings multiple. Curious how those moving parts still support a higher fair value than the analyst target? The full story spells out the earnings path, margin reset, and discount rate that underpin that $14.00 figure.

Result: Fair Value of $14.00 (OVERVALUED)

However, if Herbalife’s tech and wellness push gains more traction than expected, or regulatory pressure eases further, the current overvaluation story could look quite different.

Another View: Earnings And Cash Flows Point To Value

The AI narrative flags Herbalife as 23.1% overvalued versus its $14.00 fair value, but the picture changes when you look at earnings and cash flows. At a P/E of 5.6x versus peers at 21.4x and a fair ratio of 13.1x, the market is pricing in a lot of risk. Is that caution justified or excessive?

Build Your Own Herbalife Narrative

If you look at the numbers and reach a different conclusion, or simply want to trust your own work, you can build a complete view in just a few minutes with Do it your way.

A great starting point for your Herbalife research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.

Looking for more investment ideas?

If Herbalife has sparked your interest, do not stop there; widen your watchlist with focused stock ideas that match how you like to invest.

• Target potential mispricings by scanning these 874 undervalued stocks based on cash flows that may offer more value than their current market prices suggest.
• Ride structural themes in artificial intelligence by checking out these 24 AI penny stocks shaping the next wave of data driven businesses.
• Tap into income focused opportunities with these 12 dividend stocks with yields > 3% that already offer dividend yields above 3%.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.